Todd Asset Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-157,752
Closed -$21M 212
2022
Q2
$21M Buy
+157,752
New +$21.5M 0.54% 88
2014
Q3
Sell
-169,905
Closed -$9.97M 219
2014
Q2
$9.97M Sell
169,905
-12,063
-7% -$706K 0.28% 121
2014
Q1
$10.5M Buy
+181,968
New +$9.75M 0.3% 115

Other funds holding DGX

Todd Asset Management's DGX Position: Q3 2022 in Review

Todd Asset Management sold out of Quest Diagnostics (DGX) in Q3 2022, closing a stake of 157,752 shares — an estimated $21M sold.

Todd Asset Management first reported a position in DGX in Q1 2014 and held it in 3 quarters. The position peaked at $21M in Q2 2022. 808 funds tracked by Wall St. Rank hold DGX as of Q3 2022.

  • Todd Asset Management reported no remaining Quest Diagnostics position as of Q3 2022 after selling out during the quarter.
  • Todd Asset Management sold 157,752 Quest Diagnostics shares in Q3 2022, an estimated $21M.
  • Todd Asset Management first reported a position in Quest Diagnostics in Q1 2014 and held it in 3 quarters.
  • Todd Asset Management's Quest Diagnostics position peaked at $21M in Q2 2022.
  • 808 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2022.

Based on Todd Asset Management's 13F filing for Q3 2022, filed 8 Nov 2022.